Home/Shionogi/Nathan McCutcheon

NM

Nathan McCutcheon

President and Chief Executive Officer

Therapeutic Areas

Infectious Diseases Antivirals HIV/AIDS Influenza COVID-19 Fragile X Syndrome Acute Ischemic Stroke Metabolic Disorders Oncology Antibiotics

Shionogi Pipeline

Drug	Indication	Phase
Investigational Oral COVID-19 Antiviral	COVID-19	Clinical
Fragile X Program	Fragile X Syndrome	Clinical
Acute Stroke Program	Acute Ischemic Stroke	Clinical
Metabolic Disorders Program	Metabolic Conditions	Clinical
Oncology Program	Cancer	Clinical
Novel Antibiotics	Bacterial Infections	Various
HIV Therapeutics	HIV/AIDS	Approved
Influenza Treatments	Influenza	Approved

Leadership Team at Shionogi

Executive Vice President and Chief Commercial Officer

Executive Vice President and Chief Global Operations Officer

Senior Vice President, Chief Human Resources Officer

Masahiro Fujita

Senior Vice President and Chief Financial Officer

Senior Vice President and General Counsel

View full Shionogi profile